Equity in Standard of Care Treatment -- Patient Navigation in Lung Cancer

Invited Speaker(s)

• 

  Brendon Stiles, MD

  Montefiore Health System / Albert Einstein School of Medicine
  Bronx, New York, United States

  Disclosure(s): , Medtronic: Consultant (Ongoing), Speaker (Ongoing); American Cancer Society: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Arcus Biosciences: Advisory Board (Terminated); Astra Zeneca: Advisory Board (Ongoing), Consultant (Ongoing); BMS: Advisory Board (Ongoing); BMS Foundation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Galvanize Therapeutics Inc: Consultant (Ongoing); Lung Cancer Research Foundation: Board member (Ongoing); Merck & Co.: Advisory Board (Ongoing), Consultant (Ongoing); Pfizer, USA: Advisory Board (Ongoing), Consultant (Ongoing); Regeneron: Consultant (Ongoing); Roche Genentech: Advisory Board (Ongoing), Consultant (Ongoing); Xalud Therapeutics: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)